149 related articles for article (PubMed ID: 15717721)
1. [Potential role of cholesterol in distinguishing malignant from benign pleural effusion].
Plavec G; Tomić I; Nidzović N; Radojcić B; Aćimović S; Bokun R
Vojnosanit Pregl; 2004; 61(6):607-11. PubMed ID: 15717721
[TBL] [Abstract][Full Text] [Related]
2. [The value of B7-H4 and carcinoembryonic antigen in diagnosing the benign and malignant pleural effusion].
Wei F; Wei Y; Li LF; Li GL; Wang GJ
Zhonghua Zhong Liu Za Zhi; 2017 Jul; 39(7):524-527. PubMed ID: 28728299
[No Abstract] [Full Text] [Related]
3. Diagnostic value of CA 72-4, carcinoembryonic antigen, CA 15-3, and CA 19-9 assay in pleural fluid. A study of 207 patients.
Villena V; López-Encuentra A; Echave-Sustaeta J; Martín-Escribano P; Ortuño-de-Solo B; Estenoz-Alfaro J
Cancer; 1996 Aug; 78(4):736-40. PubMed ID: 8756365
[TBL] [Abstract][Full Text] [Related]
4. Use of cholesterol and soluble tumour markers CEA and syndecan-2 in pleural effusions in cases of inconclusive cytology.
Gulyas M; Fillinger J; Kaposi AD; Molnar M
J Clin Pathol; 2019 Aug; 72(8):529-535. PubMed ID: 31028099
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of soluble receptor-binding cancer antigen expressed on SiSo cells and carcinoembryonic antigen in differentiating malignant from benign pleural effusion.
Dong J; Sun G; Zhu H
Tumour Biol; 2016 Mar; 37(3):3257-64. PubMed ID: 26438059
[TBL] [Abstract][Full Text] [Related]
6. Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions.
Porcel JM; Vives M; Esquerda A; Salud A; Pérez B; Rodríguez-Panadero F
Chest; 2004 Dec; 126(6):1757-63. PubMed ID: 15596670
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic usefulness of tumour marker levels in pleural effusions of malignant and benign origin.
Kuralay F; Tokgöz Z; Cömlekci A
Clin Chim Acta; 2000 Oct; 300(1-2):43-55. PubMed ID: 10958862
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic utility of pleural fluid and serum markers in differentiation between malignant and non-malignant pleural effusions.
Korczynski P; Krenke R; Safianowska A; Gorska K; Abou Chaz MB; Maskey-Warzechowska M; Kondracka A; Nasilowski J; Chazan R
Eur J Med Res; 2009 Dec; 14 Suppl 4(Suppl 4):128-33. PubMed ID: 20156743
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic value of CEA in pleural fluid for differential diagnosis of benign and malign pleural effusion.
Radjenovic-Petkovic T; Pejcic T; Nastasijević-Borovac D; Rancic M; Radojkovic D; Radojkovic M; Djordjevic I
Med Arh; 2009; 63(3):141-2. PubMed ID: 20088159
[TBL] [Abstract][Full Text] [Related]
10. [Tumor markers in pleural effusions in bronchogenic carcinoma and tuberculosis].
Plavec G; Ninković M; Kozlovacki G; Lazarov A; Tatić V
Vojnosanit Pregl; 2002; 59(1):23-8. PubMed ID: 11928185
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic value of soluble B7-H4 and carcinoembryonic antigen in distinguishing malignant from benign pleural effusion.
Jing X; Wei F; Li J; Dai L; Wang X; Jia L; Wang H; An L; Yang Y; Zhang G; Cheng Z
Clin Respir J; 2018 Mar; 12(3):986-990. PubMed ID: 28127951
[TBL] [Abstract][Full Text] [Related]
12. CEA, CA 15-3 and CYFRA 21-1 in serum and pleural fluid of patients with pleural effusions.
Romero S; Fernández C; Arriero JM; Espasa A; Candela A; Martín C; Sánchez-Payá J
Eur Respir J; 1996 Jan; 9(1):17-23. PubMed ID: 8834328
[TBL] [Abstract][Full Text] [Related]
13. Limited additive value of pleural fluid carcinoembryonic antigen level in malignant pleural effusion.
Riantawan P; Sangsayan P; Bangpattanasiri K; Rojanaraweewong P
Respiration; 2000; 67(1):24-9. PubMed ID: 10705258
[TBL] [Abstract][Full Text] [Related]
14. [Diagnostic value of the combined determination of carcinoembryonic antigen (CEA) in pleural effusion and serum with an enzyme immunoassay (EIA). Sensitivity, specificity and relation to tumor type].
Klech H; Rona G; Hutter C; Bayer PM; Kummer F
Wien Klin Wochenschr; 1986 Sep; 98(17):564-73. PubMed ID: 3020811
[TBL] [Abstract][Full Text] [Related]
15. CEA and CA 549 in serum and pleural fluid of patients with pleural effusion.
Hernández L; Espasa A; Fernández C; Candela A; Martín C; Romero S
Lung Cancer; 2002 Apr; 36(1):83-9. PubMed ID: 11891038
[TBL] [Abstract][Full Text] [Related]
16. [Evaluation of the diagnosis value of carcinoembryonic antigen in malignant pleural effusion].
Yu YX; Tong ZH; Zhou XX; Liang LR; Wang Z; Xu LL; Wang XJ; Wu YB; Li HJ; Lu Z
Zhonghua Yi Xue Za Zhi; 2018 Feb; 98(6):432-435. PubMed ID: 29429254
[No Abstract] [Full Text] [Related]
17. Diagnosis of pleural effusions. Experience with clinical studies, 1986 to 1990.
Marel M; Stastny B; Melínová L; Svandová E; Light RW
Chest; 1995 Jun; 107(6):1598-603. PubMed ID: 7781353
[TBL] [Abstract][Full Text] [Related]
18. Elevated level of carcinoembryonic antigen in nonmalignant pleural effusions.
Garcia-Pachon E; Padilla-Navas I; Dosda MD; Miralles-Llopis A
Chest; 1997 Mar; 111(3):643-7. PubMed ID: 9118701
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic value of tumor markers for differentiating malignant and benign pleural effusions of Iranian patients.
Ghayumi SM; Mehrabi S; Doroudchi M; Ghaderi A
Pathol Oncol Res; 2005; 11(4):236-41. PubMed ID: 16388321
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of cholesterol in pleural effusions.
Ram KN; Sing RS
J Assoc Physicians India; 1995 Nov; 43(11):748-50. PubMed ID: 8773031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]